Taking to social media today, Kuria claimed that the agency fails to regulate the industry, allowing overpriced and substandard drugs to flood the market.
He cited a personal account from an Indian doctor who found Kenyan medicines 10 times costlier and 10% less potent than those in other countries.
Kuria's remarks come amid growing concerns over Kenya's healthcare system, where counterfeit drugs are a persistent problem.
A 2019 WHO survey revealed that 30% of medicines in Kenya were substandard.
Kuria urged MP Abraham Kirwa, recently returned after a two-year recovery from a stroke, to summon the Ministry of Health to address these issues.
The allegations have sparked calls for an overhaul of the PPB, with critics pointing to its inability to curb cartels despite repeated scandals.
The Finance Bill 2025's proposed tax changes could further inflate drug prices, exacerbating the crisis.
Kuria's bold statement has reignited debates on corruption and accountability in country's healthcare sector.
Tags:
People